Literature DB >> 29204696

Patients' perspective on bowel resection for inflammatory bowel disease.

Milton Mui1, Vinna An2, Jane Lovell2, Basil D'Souza2, Rodney Woods2.   

Abstract

PURPOSE: The study aimed to determine whether patients are receiving adequate counselling about elective bowel resection and timely surgery for inflammatory bowel disease (IBD).
METHODS: Patients with IBD who underwent an elective bowel resection in a tertiary referral centre between April 2012 and Dec 2014 were identified from a prospective database. Patients under the age of 16 years were excluded from the study. Patients were contacted over the phone to complete a questionnaire regarding their perspective on their surgery, including the consultations that took place, preparedness and timing of surgery, as well as patient attitude towards bowel resection and satisfaction with post-operative outcomes. Demographic details were recorded.
RESULTS: Thirty-one patients participated in the study. Twenty-one (68%) patients were diagnosed with Crohn's disease, nine (29%) were diagnosed with ulcerative colitis, and one (3%) had indeterminate colitis. Twenty-seven (87%) patients reported that the timing of the initial consultation regarding the option of bowel resection was appropriate. Twenty-five (81%) patients felt prepared after a consultation with the surgical team with regard to perioperative issues and potential complications. Fourteen (45%) patients reported that the timing of bowel resection was appropriate, while 15 (48%) reported that it should have been earlier. A significant improvement in patient's pre- and post-operative attitudes towards bowel resection was demonstrated (p = 0.004). Thirty (97%) patients were either happy or very happy with their results and symptom improvement post-bowel resection.
CONCLUSION: Most patients are receiving adequate counselling about elective bowel resection for IBD, although there is room for improvement for preoperative education and optimising timing of surgery.

Entities:  

Keywords:  Colectomy; Decision-making; Inflammatory bowel diseases; Patient satisfaction; Proctocolectomy restorative

Mesh:

Year:  2017        PMID: 29204696     DOI: 10.1007/s00384-017-2941-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  16 in total

1.  Health-related quality of life in patients with Crohn's disease: influence of surgical operation--a prospective trial.

Authors:  W Tillinger; C Mittermaier; H Lochs; G Moser
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

Review 2.  Quality of life of patients with inflammatory bowel disease after surgery.

Authors:  R S McLeod; N N Baxter
Journal:  World J Surg       Date:  1998-04       Impact factor: 3.352

3.  Risk of infectious complications in patients taking glucocorticosteroids.

Authors:  A E Stuck; C E Minder; F J Frey
Journal:  Rev Infect Dis       Date:  1989 Nov-Dec

Review 4.  Surgical treatment of Crohn's disease of the small bowel or ileocecum.

Authors:  L Hultén
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

5.  Quality of life after surgery for Crohn's disease: a psychosocial survey.

Authors:  S Meyers; J S Walfish; D B Sachar; A J Greenstein; A G Hill; H D Janowitz
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

Review 6.  Conventional medical management of inflammatory bowel disease.

Authors:  Daniel Burger; Simon Travis
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

7.  Patient preferences between surgical and medical treatment in Crohn's disease.

Authors:  Christopher M Byrne; Michael J Solomon; Jane M Young; Warwick Selby; James D Harrison
Journal:  Dis Colon Rectum       Date:  2007-05       Impact factor: 4.585

8.  Treatment decisions for breast carcinoma: patient preferences and physician perceptions.

Authors:  Eduardo Bruera; Jie S Willey; J Lynn Palmer; Marguerite Rosales
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

9.  Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis.

Authors:  Jonathan I Warman; Burton I Korelitz; Mark R Fleisher; Ram Janardhanam
Journal:  J Clin Gastroenterol       Date:  2003-09       Impact factor: 3.062

10.  Terminal ileal Crohn's disease: conservative surgeon and aggressive physician?

Authors:  U Shariff; H Narula; W Speake; S Brown
Journal:  Colorectal Dis       Date:  2009-02-25       Impact factor: 3.788

View more
  2 in total

Review 1.  Surgery versus Medical Therapy in Luminal Ileocecal Crohn's Disease.

Authors:  Michele Carvello; Silvio Danese; Antonino Spinelli
Journal:  Clin Colon Rectal Surg       Date:  2022-01-17

2.  Assessment of Patients' Future Outlook after Bowel Resection in Crohn's Disease.

Authors:  Shasha Tang; Xiaolong Ge; Weilin Qi; Wei Liu; Qian Cao; Wei Zhou
Journal:  Gastroenterol Res Pract       Date:  2019-01-09       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.